Username: Password:

News and analysis of Biotech stocks. No buy or sell recommendations.

Visit SeekingAlpha Biotech Stocks

hr

China Biotech in Review: Company Profiles and Drug Advancement

Posted on August 03, 2008

In ChinaBio Today, we profiled two China biotechs last week. One, Shenogen Pharma Group, recently won one of the two Most Promising Company awards at the ChinaBio Investor Forum, held in early July in Shanghai (see story). Shenogen combines facets of Western and Eastern pharmaceutical practices. It uses a molecule from traditional Chinese medicine to target a novel receptor that Shenogen has discovered, which the company expects will prove to play a significant role in breast cancer. The Shenogen compound could eventually become as important as tamoxifen. With this ambitious goal, and it...

Original article link


Tags:
biotech , biotechnology , disease , pharma
default explanation